Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection

被引:36
作者
Zhou, Li [1 ]
Rui, Jing-An [1 ]
Wang, Shao-Bin [1 ]
Chen, Shu-Guang [1 ]
Qu, Qiang [1 ]
Chi, Tian-Yi [1 ]
Wei, Xue [1 ]
Han, Kai [1 ]
Zhang, Ning [1 ]
Zhao, Hai-Tao [1 ]
机构
[1] Beijing Union Med Coll Hosp, Chinese Acad Med Sci, Dept Gen Surg, Beijing 100032, Peoples R China
关键词
hepatocellular carcinoma; male; female; curative hepatic resection; prognostic factor;
D O I
10.1002/jso.20678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: Curative hepatic resection (CHR) was a modality that provides possibility of long-term survival for hepatocellular carcinoma (HCC). So far, prognostic factors of male patients with HCC after CHR remain unclear. Purposes of the present study were to identify these factors and to compare them with those for females. Methods: Consecutive 151 male and 23 female patients with HCC undergoing CHR were enrolled in this retrospective study. Their prognostic factors were identified by uni- and multi-variate statistical analysis. Results: One-, three- and five-year overall and disease-free survival of male patients were 82.4, 51.5, and 43.6%, and 65.8, 33.7, and 21.7%, respectively, with no significant differences compared to females. Univariate analysis showed that tumor size, TNM staging, Edmondson-Steiner grade, serum a-fetoprotein (AFP) level, presence of portal vein tumor thrombosis (PVTT) and satellite nodule were significant for males with HCC, but only Edmondson-Steiner grade, presence of PVTT and satellite nodule were independent. For females, Edmondson-Steiner grade was the single potential indicator for survival. Conclusions: Malignant degree and invasive phenotypes were main factors that independently influenced survival of male patients with HCC after CHR. Among them, histological grade, which was also potentially significant for females, was the most powerful survival predictor.
引用
收藏
页码:298 / 303
页数:6
相关论文
共 32 条
[1]  
Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO
[2]  
2-S
[3]   Longer survival in female than male with hepatocellular carcinoma [J].
Dohmen, K ;
Shigematsu, H ;
Irie, K ;
Ishibashi, H .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (03) :267-272
[4]   QUANTITATION OF ESTROGEN AND ANDROGEN RECEPTORS IN HEPATOCELLULAR-CARCINOMA AND ADJACENT NORMAL HUMAN LIVER [J].
EAGON, PK ;
FRANCAVILLA, A ;
DILEO, A ;
ELM, MS ;
GENNARI, L ;
MAZZAFERRO, V ;
COLELLA, G ;
VANTHIEL, DH ;
STARZL, TE .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (09) :1303-1308
[5]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[6]  
2-E
[7]  
Fukuda S, 2005, HEPATO-GASTROENTEROL, V52, P1163
[8]  
Hanazaki K, 2001, AM J GASTROENTEROL, V96, P1243, DOI 10.1111/j.1572-0241.2001.03634.x
[9]  
Hanazaki K, 2002, HEPATO-GASTROENTEROL, V49, P518
[10]  
Hermanek P, 1992, TNM CLASSIFICATION M, P104